02:10 PM EDT, 03/28/2024 (MT Newswires) -- Avalo Therapeutics ( AVTX ) shares skyrocketed amid heavy trading Thursday after the company completed the acquisition of privately held AlmataBio and said late Wednesday it entered into a private placement of preferred stock and warrants for up to $185 million.

Shares catapulted 385% as intraday trading volume jumped to over 22 million from a daily average of about 92,000.

Nexalin Technology ( NXL ) unveiled Thursday positive results from a clinical study evaluating the company's second-generation device to reduce pain in veteran patients with Mild Traumatic Brain Injury.

Shares soared 100% as intraday trading volume shot to more than 3 million from a daily average of about 336,000.

Imunon ( IMNN ) reported on Thursday a 2023 net loss per share of $2.16, compared with a net loss of $5.03 a year ago.

Shares advanced 32% as intraday trading volume rose to more than 1.1 million versus the stock's daily average of about 159,000.

Price: 23.05, Change: +18.30, Percent Change: +385.26